Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

Nature Genetics

Volumn 43, Issue 5, 2011, Pages 482-488

  Ford, Christopher B ^a   Lin, Philana Ling ^b   Chase, Michael R ^a   Shah, Rupal R ^a   Iartchouk, Oleg ^c   Galagan, James ^d,e,f   Mohaideen, Nilofar ^g   Ioerger, Thomas R ^h   Sacchettini, James C ^g   Lipsitch, Marc ^a   Flynn, Joanne L ⁱ   Fortune, Sarah M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Boston University   (United States)

^e BOSTON UNIVERSITY   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g TEXAS A AND M UNIVERSITY   (United States)

^h Texas AandM University   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; DNA DAMAGE; GENOME ANALYSIS; IN VIVO STUDY; MACACA; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MACACA FASCICULARIS; MODELS, GENETIC; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MACACA; MYCOBACTERIUM TUBERCULOSIS;

EID: 79955460244     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.811     Document Type: Article

References (31)

1. Balcells, M.E., Thomas, S.L., Godfrey-Faussett, P. & Grant, A.D. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg. Infect. Dis. 12, 744-751 (2006). (Pubitemid 43726847)
2. Cattamanchi, A. et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin. Infect. Dis. 48, 179-185 (2009).
3. Denver, D.R., Morris, K., Lynch, M. & Thomas, W.K. High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome. Nature 430, 679-682 (2004). (Pubitemid 39061683)
4. Haag-Liautard, C et al. Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila. Nature 445, 82-85 (2007). (Pubitemid 46067305)
5. Lynch, M. et al. A genome-wide view of the spectrum of spontaneous mutations in yeast. Proc Natl. Acad. Sci. USA 105, 9272-9277 (2008).
6. Capuano, S.V. III et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831-5844 (2003).
7. Lin, P.L. et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77, 4631-4642 (2009).
8. Li, H., Ruan, J. & Durbin, R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 18, 1851-1858 (2008).
9. Ioerger, T.R. et al. Genome analysis of multi-and extensively-drug- resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE 4, e7778 (2009).
10. Hernandez, D., Francois, P., Farinelli, L., Osteras, M. & Schrenzel, J. De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. Genome Res. 18, 802-809 (2008). (Pubitemid 351645070)
11. Gutierrez-Vazquez, J.M. Studies on the rate of growth of mycobacteria. I. Generation time of Mycobacterium tuberculosis on several solid and liquid media and effects exerted by glycerol and malachite green. Am. Rev. Tuberc. 74, 50-58 (1956).
12. Gill, W.P. et al. A replication clock for Mycobacterium tuberculosis. Nat Med. 15, 211-214 (2009).
13. Muñoz-Elías, E.J. et al. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73, 546-551 (2005). (Pubitemid 40041149)
14. Barry, C.E. et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev. Microbiol. 7, 845-855 (2009).
15. Lin, P.L. & Flynn, J.L. Understanding latent tuberculosis: a moving target. J. Immunol. 185, 15-22 (2010).
16. Sarkar, S., Ma, W.T. & Sandri, G.H. On fuctuation analysis: a new, simple and effcient method for computing the expected number of mutants. Genetica 85, 173-179 (1992).
17. Lang, G.I. & Murray, A.W. Estimating the per-base-pair mutation rate in the yeast Saccharomyces cerevisiae. Genetics 178, 67-82 (2008). (Pubitemid 351398732)
18. Boshoff, H.I.M., Reed, M.B., Barry, C.E. & Mizrahi, V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113, 183-193 (2003). (Pubitemid 36514970)
19. Werngren, J. & Hoffner, S.E. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J. Clin. Microbiol. 41, 1520-1524 (2003). (Pubitemid 36428098)
20. Telenti, A. et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-650 (1993). (Pubitemid 23083244)
21. Nathan, C & Shiloh, M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl. Acad. Sci. USA 97, 8841-8848 (2000). (Pubitemid 30626635)
22. Ng, V.H., Cox, J.S., Sousa, A.O., MacMicking, J.D. & McKinney, J.D. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52, 1291-1302 (2004). (Pubitemid 38746304)
23. Sassetti, C.M. & Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100, 12989-12994 (2003). (Pubitemid 37340013)
24. Boshoff, H.I., Durbach, S.I. & Mizrahi, V. DNA metabolism in mycobacterium tuberculosis: implications for drug resistance and strain variability. Scand. J. Infect Dis. 33, 101-105 (2001). (Pubitemid 32177992)
25. Fenhalls, G. et al. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect. Immun. 70, 6330-6338 (2002). (Pubitemid 35192725)
26. Saint-Ruf, C., Pesut, J., Sopta, M. & Matic, I. Causes and consequences of DNA repair activity modulation during stationary phase in Escherichia coli. Crit Rev. Biochem. Mol. Biol. 42, 259-270 (2007). (Pubitemid 47237763)
27. Bjedov, I. et al. Stress-induced mutagenesis in bacteria. Science 300, 1404-1409 (2003). (Pubitemid 36638154)
28. Cohen, T., Lipsitch, M., Walensky, R.P. & Murray, M. Benefcial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc. Natl. Acad. Sci. USA 103, 7042-7047 (2006).
29. Perriëns, J.H. et al. Increased mortality and tuberculosis treatment failure rate among human immunodefciency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am. Rev. Respir Dis. 144, 750-755 (1991).
30. Lee, J., Remold, H.G., Ieong, M.H. & Kornfeld, H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176, 4267-4274 (2006). (Pubitemid 44264406)
31. Kurtz, S. et al. Versatile and open software for comparing large genomes. Genome Biol. 5, R12 (2004).